BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8501152)

  • 21. Exercise induces two types of human luteal dysfunction: confirmation by urinary free progesterone.
    Beitins IZ; McArthur JW; Turnbull BA; Skrinar GS; Bullen BA
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1350-8. PubMed ID: 1902847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased follicular phase gonadotropin secretion is associated with impaired estradiol and progesterone secretion during the follicular and luteal phases in normally menstruating women.
    Schweiger U; Laessle RG; Tuschl RJ; Broocks A; Krusche T; Pirke KM
    J Clin Endocrinol Metab; 1989 May; 68(5):888-92. PubMed ID: 2497129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential responses to a simulated implantation signal at various stages of the luteal phase in women.
    Woodward AJ; Lenton EA
    J Clin Endocrinol Metab; 1992 May; 74(5):999-1004. PubMed ID: 1569178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
    Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
    J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonadotropic stimulation of inhibin secretion by the human ovary during the follicular and early luteal phase of the cycle.
    Tsonis CG; Messinis IE; Templeton AA; McNeilly AS; Baird DT
    J Clin Endocrinol Metab; 1988 May; 66(5):915-21. PubMed ID: 3129450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
    Sherman BM; Chapler FK; Crickard K; Wycoff D
    J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of relaxin in glycodelin secretion.
    Stewart DR; Erikson MS; Erikson ME; Nakajima ST; Overstreet JW; Lasley BL; Amento EP; Seppala M
    J Clin Endocrinol Metab; 1997 Mar; 82(3):839-46. PubMed ID: 9062493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonadotropin and inhibin concentrations in early pregnancy in women with and without corpora lutea.
    Santoro N; Schneyer AL; Ibrahim J; Schmidt CL
    Obstet Gynecol; 1992 Apr; 79(4):579-85. PubMed ID: 1553181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function.
    Polan ML; Daniele A; Russell JB; DeCherney AH
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1284-91. PubMed ID: 3097055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
    Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
    Balogh A; Ditrói F; Lampé LG
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
    J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stress and the menstrual cycle: short- and long-term response to a five-day endotoxin challenge during the luteal phase in the rhesus monkey.
    Xiao E; Xia-Zhang L; Ferin M
    J Clin Endocrinol Metab; 1999 Feb; 84(2):623-6. PubMed ID: 10022427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.